In a previous investigation it was determined that Pseudomonas aeruginosa cells taken directly from a mouse in vivo growth system were significantly more susceptible to nonopsonic phagocytosis by macrophages than were similar cells after being washed in buffer (
Pseudomonas aeruginosa is an opportunistic pathogen capable of causing life-threatening disease in immunocompromised individuals. Those especially at risk include patients with severe bums, cancer, diabetes, or cystic fibrosis. In the case of some patients with cystic fibrosis, initial P. aeruginosa infections can be suppressed after antibiotic treatment (5) . This may involve not only antibiotic action but also non-immune clearance mechanisms. These latter mechanisms encompass both the mucociliary system and nonopsonic phagocytosis by pulmonary alveolar macrophages (18) . Nonopsonic phagocytosis involves association of macrophages and bacteria in the absence of external opsonins. This mode of phagocytosis has been considered to be a relatively inefficient process (1) and thus relatively unimportant to the clearance of this organism.
On repeated infection with P. aeruginosa, lung function of an individual with cystic fibrosis rapidly deteriorates, and bacteria are less easily suppressed. Thus, it seemed important to understand the mechanisms by which macrophages initially interact with P. aeruginosa. These phagocytes are often the first host immune cells to infiltrate sites of infection, have been proposed to be a primary line of defense against lung infection (16) , and play a dual role in bacterial clearance by interacting directly with bacterial cells and releasing potent immunomodulators (17) . In addition, they are involved in antigen presentation to T cells as part of antigen recognition in the cellular and humoral immune responses.
In a previous investigation, it was determined that P. aeruginosa cells taken directly from an in vivo growth system were significantly more susceptible to phagocytosis by mouse macrophage cell line P388D1 than were identical P. aeruginosa cells after being washed in buffer (8) . The data presented in this paper demonstrate that the factor involved * Corresponding author.
in promoting the phagocytosis of in vivo-grown bacteria was present in the supernatant removed from these cells by centrifugation. We present studies which identified the factor as fibronectin, and we examine the bacterial and phagocyte requirements for phagocytosis promotion by fibronectin.
MATERIALS AND METHODS
Bacterial strains and in vitro growth conditions. P. aeruginosa PAQ1 strain H103, a laboratory serotype 5 isolate (11) , and M2, a strain traditionally used for mouse pathogenicity studies (20) , were maintained on Trypticase soy agar (Becton, Dickinson & Co., Cockeysville, Md.). Before assay, in vitro cells were inoculated from these plates and grown for 20 h, shaken vigorously (200 rpm), in Trypticase soy broth or for 20 h on Trypticase soy agar at 37°C. These stationaryphase cells, with an optical density at 600 nm greater than 2.0, were washed in phosphate-buffered saline (PBS) (pH 7.2) and suspended to a concentration of 109/ml before experimentation.
Bacterial growth in vivo. Chambers for implantation into mice were constructed from 1-ml polypropylene syringe barrels as previously described (4) . Chambers for implantation into rats were similarly constructed from 3-ml polypropylene syringe barrels (9) . The P. aeruginosa culture used to inoculate the chambers was grown overnight in proteose peptone no. 2 broth (Difco Laboratories, Detroit, Mich.) and diluted in physiological saline to give a chamber inoculum of approximately 104 bacteria per ml. Chambers for implantation into mice received a volume of 100 ,ul of the diluted culture, whereas chambers for rats received 500 ,lI. The animals were anesthetized by intraperitoneal injection of sodium pentobarbitol (Somnotol; M.T.C. Pharmaceuticals, Mississauga, Ontario, Canada) at 0.06 mg/g of body weight for mice and 0.14 mg/g for rats. Chambers were implanted, four per animal, through a small longitudinal incision in the abdomen of the animal. The chambers were removed after 3 days, at which stage the bacterial cultures had reached their maximal density of 108 to 109 cells per ml (9 (19) previously showed that results obtained with this visual phagocytosis assay gave data comparable to the findings of chemiluminescence and electron microscopy studies.
When utilized, goat anti-human fibronectin serum (Sigma) was incubated with supernatant or fibronectin for 15 min at room temperature before addition to the macrophage monolayer. Antibody was used at the recommended ratio of 1 p.g/p.g of fibronectin.
Characterization of the phagocytosis-promoting factor. To characterize the phagocytosis-promoting factor, in vivo supernatant was passed over a fast pressure liquid chromatography (FPLC) Superose 12 gel sieving column (Pharmacia, Dorval, Quebec, Canada). The flow rate was 30 ml/h, and elution buffer consisted of 20 mM Tris (ICN Biomedicals, Cleveland, Ohio)-0.1 M NaCl (BDH Chemicals, Toronto, Ontario, Canada) (pH 7.5). Fractions were collected, lyophilized, suspended in distilled water, and dialyzed extensively against distilled water. The final suspension volume was the same as the volume of supernatant initially added to the column. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (7) and Western immunoblotting techniques (10) were performed as described previously. For Western immunoblots, 100 ,ug of antifibronectin antibody was utilized per blot.
RESULTS
Enhancement of phagocytosis by in vivo supernatant. In a previous investigation it was determined that P. aeruginosa M2 cells taken directly from an in vivo system were significantly more susceptible to phagocytosis by mouse macrophage cell line P388D1 than were identical P. aeruginosa cells that had been centrifuged and suspended in buffer (8) . P. aeruginosa cells were grown for 3 days in the peritoneal cavity of laboratory mice. Bacteria were contained in 1-cm-long plastic chambers, sealed at both ends with 0.22-,um-pore-size membrane filters (4), allowing free exchange of peritoneal fluids and bacterial products while prohibiting access by immune cells or escape of bacteria. Upon removal of chambers, bacteria were separated from the fluid in the chamber by centrifugation. This decanted fluid was called the in vivo supernatant.
Initially, we wished to determine whether the decreased phagocytosis of washed in vivo-grown bacteria was related to effects of the washing procedure on the organisms or was due to removal of some phagocytosis-promoting factor in the in vivo supernatant. To determine whether in vivo supernatant could be added back to the washed bacteria and still facilitate uptake of bacteria by macrophages, a visual assay of phagocytosis was performed (3). Mouse in vivo-grown M2 cells and mouse macrophage cell line P388D1 were used in these initial studies to provide continuity with the previous study.
It was observed that there was indeed a phagocytosispromoting factor obtained from in vivo chambers, which could be separated from the bacteria easily by centrifugation at 12,000 x g for 10 min and added back to again facilitate bacterial association with macrophages (Table 1) . At a bacteria-to-macrophage ratio of 20 to 1, an average of 2.9 washed bacteria became associated per macrophage as compared to 7.7 bacteria taken up in the presence of in vivo supematant. This difference was found to be statistically significant in seven of eight assays performed (P < 0.005, Student's t test) and marginally significant (P < 0.1) in the other assay. This phagocytosis-enhancing factor was titerable in this system, as decreasing amounts of added supernatant resulted in progressively decreasing levels of bacterial uptake (Table 1) .
To determine whether these phenomena were restricted to the mouse in vivo system or to this particular strain of P. aeruginosa, the same studies were carried out using ratgrown bacteria. Almost identical results were obtained in the rat model, utilizing both strain M2 and laboratory wild-type strain H103 (Table 2) . Additionally, rat supernatant from in vivo chambers could effectively promote uptake of in vitrogrown strain H103 on Trypticase soy agar (Table 2) . Similar results were obtained using in vitro-grown strain H103 and unelicited mouse peritoneal macrophages. In this case, addition of rat in vivo supematant increased bacterial association from 2.1 to 7.0 bacteria per phagocyte. These differences were found to be statistically significant in all assays performed (P < 0.005, Student's t test). It was thus evident that the mouse macrophage cell line P388D1 could be used as a model for unelicited mouse peritoneal macrophages in this system. Thus, the remainder of our studies centered on measuring promotion of association of in vitro-grown strain H103 with P388D1 cells. This particular system was chosen because of the relative ease of working with in vitro-grown organisms. However, it was necessary to determine whether growth conditions affected in vivo supematant-promoted phagocytosis. Strain H103 was grown either in rapidly agitated (200 rpm) Trypticase soy broth or on a plate of Trypticase soy agar. Although uptake of agitated bacteria could not be promoted by using in vivo supernatant from rat peritoneal chambers, phagocytosis of plate-grown organisms was significantly enhanced (Table 3) on Trypticase soy agar plates were used for subsequent studies.
Characterization of the phagocytosis-promoting factor. To further characterize the phagocytosis-promoting factor, in vivo supernatant was fractionated on an FPLC Superose 12 gel sieving column, and peaks were collected in four pools (Fig. 1) . After extensive dialysis and concentration, the phagocytosis-promoting activity of these pools was assessed. It was observed that pool A strongly enhanced phagocytosis, pool B was less effective, and pools C and D were ineffective (Table 4) .
These data established that the factor was of high molecular weight. Thus, we considered three possible candidates for the phagocytosis-promoting factor, namely, antibody, complement, and fibronectin, each of which had been previously shown to promote phagocytosis (14) . The ease of dissociation of the factor from cells (by centrifugation and washing) and the use of naive mice in our experiments seemed to rule out antibody. In addition, the activity was stable to heating to 100°C for 10 min (Table 4) , thus ruling out complement, which is inactivated at this temperature. Therefore we tested for the presence of fibronectin by using a commercially available anti-human fibronectin antibody preparation. Use of this antiserum was possible owing to the strong evolutionary and antigenic conservation of fibronectin (12) . By Western immunoblotting with goat anti-human fibronectin antiserum, in vivo supernatant and pool A reacted strongly, pool B reacted less strongly, and pools C and D failed to react. Thus the order of reactivity matched the ability to enhance phagocytosis (Table 4) . Pool A was partially resolved by FPLC into two peaks, 1 and 2 (Fig. 1) . Fibronectin was present in peak 2 (Fig. 2, lane 2) but not peak 1 (Fig. 2, lane 1) . Snmall amounts of fibronectin were detectable in pool B (Fig. 2, lane 3) but none in pools C or D. This suggested that the fibronectin content, and thus the phagocytosis-promoting activity of pool B, was probably due to incomplete separation of peak 2 and pool B.
To confirm fibronectin as the phagocytosis-promoting factor, antifibronectin serum was incubated with in vivo supernatant for 15 min before phagocytosis assays. The antiserum significantly reduced, to the level of the PBS control, the phagocytosis-promoting ability of the in vivo supernatant (Table 5) .
A commercially available preparation of bovine plasma fibronectin was tested for phagocytosis-promoting activity at 100 ,ug/ml. This concentration of fibronectin increased bac- (Table 5 ). In further experiments, it was determined that concentrations as small as 12 ,ug of fibronectin per ml resulted in enhancement of phagocytosis.
Requirement for bacteria. To determine whether bacteria must be present to allow production or possibly activation of this factor, saline-containing chambers were incubated in vivo, and their fluid contents were assessed for phagocytosis promotion. It was observed that saline chamber supernatants from both mice and rats were indeed capable of enhancing phagocytosis of in vitro-grown P. aeruginosa H103 from 4.5 to 24.1 and 11.5 bacteria per macrophage, respectively ( Table 6 ). The phagocytosis-promoting factor in saline-containing chamber supernatants was apparently fibronectin, since antifibronectin antibodies significantly reduced the ability of these supernatants to promote phagocytosis (data not shown).
To establish the time at which the phagocytosis-promoting factor appeared in vivo, bacteria-and saline-containing chambers were incubated in the peritoneums of mice and rats for 4, 8, 16, 24, 44 , and 68 h. Supernatants from these chambers were tested for phagocytosis enhancement. In both saline and bacterial chambers, phagocytosis-promoting activity appeared within 4 h in mice and within 16 h in rats ( Table 6 ). The degree of phagocytosis enhancement did not differ significantly between bacteria-containing and salinecontaining chambers in either animal system, although mouse supernatants were substantially more active than their rat counterparts.
The emergence of fibronectin in these chambers correlated well with the ability to enhance bacterial association with P388D1 cells. Fibronectin was not detectable in Western blots of rat 4-h supernatants but was easily seen at 24 h (Fig.  3) . In mice, however, this protein was found at a substantial concentration at all time points (Fig. 3) . By comparison with the intensity of staining on Western immunoblots of a standard fibronectin preparation (Fig. 3, lane 13) , we could estimate that the concentration of fibronectin in the chambers reached levels as high as or higher than 1 mg/ml (i.e., 100 p.g per mouse chamber, 500 ,ug per rat chamber).
DISCUSSION
The data in this paper demonstrated that a phagocytosispromoting factor was found in the supernatant obtained from 1 P. aeruginosa chambers incubated in the peritoneal cavities of laboratory mice and rats. This factor could be separated easily from bacteria by centrifugation and then added back to again facilitate association of P. aeruginosa with mouse unelicited peritoneal macrophages or macrophage cell line P388D1 (Tables 1 and 2 ). The ease of removal of this factor suggested that it was not an opsonin such as antibody or complement, which typically have very high binding affinities and thus remain attached to cells during centrifugation. Furthermore, treatment of in vivo supernatant at 100°C for 10 min failed to affect its ability to enhance phagocytosis (Table 4 ). This treatment would have inactivated any complement or antibody proteins present.
This phenomenon was reproduced with two P. aeruginosa strains of different serotypes, using either mice or rats as the in vivo chamber host. Additionally, rat in vivo supernatant could effectively promote uptake of plate-grown bacteria by P388D1 cells or unelicited mouse peritoneal macrophages. The similar results obtained with these two macrophage cell types confirmed that mouse macrophage cell line P388D1 is an appropriate model for unelicited mouse peritoneal macrophages, as previously demonstrated in studies of opsonized phagocytosis of P. aeruginosa (3) .
The fact that fibronectin copurified with phagocytosispromoting activity on a gel sieving column suggested to us that fibronectin might be the factor in question. Fibronectin has been shown previously to activate macrophages for increased adherence (2), C3 and Fc receptor-mediated phagocytosis of coated erythrocytes (13, 22) , and maintenance of antistaphylococcal activity (15) . However, no reports of its effects on nonopsonic phagocytosis or on phagocytosis of a gram-negative bacterium have appeared to date.
In our studies, the phagocytosis-promoting activity of a commercially available fibronectin preparation and the negating effects of antifibronectin antibodies (Table 5 ) strongly supported the conclusion that fibronectin was the active component of the in vivo supernatant. Whether this protein was acting as an opsonin or macrophage activator is currently being determined. This latter possibility seems more likely, however, as fibronectin displays a low binding affinity for P. aeruginosa (21) .
The similar phagocytosis enhancement produced by in vivo supernatants from chambers containing bacteria or saline (Table 6 ) suggested that bacterial presence was not required to elicit the fibronectin response. Confirmation of this was obtained by using Western blotting techniques (Fig.  3) . These data suggested that fibronectin increased in concentration over time in the peritoneal chambers, possibly due to surgical injury or implantation of a foreign body (the chamber), but not necessarily in response to the bacteria. There is a considerable precedent for this, as fibronectin is commonly found at wound sites (6) . It should be noted that P. aeruginosa commonly initiates infections at sites of injury, including wounds and burns.
The presence of fibronectin early in the mouse time-course experiments may have indicated a higher level of fibronectin in the normal peritoneum of mice as compared to rats.
Alternatively, the mouse system may have had more efficient delivery of fibronectin to the site of injury. The lower maximal levels of bacterial association with macrophages, found using rat in vivo supernatant, may however reflect a macrophage preference for homologous fibronectin, since the macrophages used were derived from mice.
The observation that the enhancement of phagocytosis of in vitro-grown organisms was dependent on whether they were grown on plates or in shaken broth suggested that there VOL. 57, 1989 was some alterable property of P. aeruginosa required for in vivo supernatant-mediated phagocytosis. P. aeruginosa grown with little or no agitation are thought to have increased quantities of pili, alginate exopolysaccharide, and possibly slime. One or more of these factors may be required for in vivo fibronectin-promoted phagocytosis. In previous papers it has been suggested that fibronectin is incapable of promoting association of mammalian cells and P. aeruginosa (21) . In these earlier studies, however, bacteria were grown with rapid agitation, and thus their uptake by phagocytes would not be expected to be influenced by fibronectin (Table   3 ).
Our current working hypothesis is that fibronectin activates macrophages to increase their level of nonopsonic uptake. Experiments are being performed to test this hypothesis and to determine the nature of the alterable bacterial property crucial to this system. Nonopsonic uptake could be seen as a very important clearance mechanism at the site of P. aeruginosa infection. These areas often display tissue injury and may therefore contain relatively high levels of fibronectin. If this is true, we would predict, based on the data presented here, that macrophages infiltrating the area could be acted upon by fibronectin and begin efficient nonopsonic clearance of P. aeruginosa. Indeed, very high levels of uptake were observed in the experiments reported here, with up to 100% of added bacteria taken up per macrophage (Table 6 ).
